ARA-290
An erythropoietin-derived research peptide examined in experimental inflammatory and nerve models.
What is it?
ARA-290 is a peptide designed from a region of the structure of erythropoietin. It is studied separately from the full erythropoietin protein.
What does the research explore?
An experimental autoimmune-neuritis study investigated inflammatory responses and tissue effects in a preclinical model.
How to interpret the evidence
Preclinical results depend on the model and study conditions. They do not establish a clinical effect, approved use or suitable administration method for these products.
Study findings apply to the material and experimental conditions used by the researchers. They do not show that a PepVision product produces the same effects, or establish a personal-use dose.
Available presentation
ARA-290 · 10 mg. Check the product page for current pricing and documentation.
Preparation and study protocols
Use a validated laboratory procedure for the exact material, solvent and study. Contact us for the available specification and lot documents. This overview does not prescribe a preparation method, administration route or dosing schedule.
Sources
For research purposes only. Not for human or animal consumption.